4//SEC Filing
GRAYZEL DAVID S. 4
Accession 0001209191-22-036145
CIK 0001718108other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 8:00 PM ET
Size
5.6 KB
Accession
0001209191-22-036145
Insider Transaction Report
Form 4
GRAYZEL DAVID S.
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-08+24,000→ 24,000 totalExercise: $2.01Exp: 2032-06-08→ Common Stock (24,000 underlying)
Footnotes (1)
- [F1]The Options shall vest in twelve equal monthly installments following the date of grant or, if earlier, upon the date of the next Annual Meeting; provided, however, that all vesting shall cease if the director resigns from the Board of Directors or otherwise ceases to serve as a director, unless the Board of Directors determines that the circumstances warrant continuation of vesting.
Documents
Issuer
Surface Oncology, Inc.
CIK 0001718108
Entity typeother
Related Parties
1- filerCIK 0001732786
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 8:00 PM ET
- Size
- 5.6 KB